CIK 0000811641
- Non-accelerated filer
- Smaller reporting company
IMMUCELL CORP /DE/
Sign in to watch- Ticker
- ICCC
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010382980
- Phone
- +1 207-878-2770
- Business address
- 56 EVERGREEN DR, PORTLAND, ME, 04103
- 4 Open-market buy Director bought 2,312 shares at an average $3.83 ($8,850)
- 4 Open-market buy Director bought 1,600 shares at an average $3.79 ($6,063)
- 4 Open-market buy Director bought 1,765 shares at an average $3.91 ($6,902)
- 4 Open-market buy Director bought 7,764 shares at an average $2.14 ($16,643)
- 4 Open-market buy Director bought 4,850 shares at an average $2.01 ($9,748)
- 4 Open-market buy Director bought 300 shares at $1.88 ($564)
- 4 Open-market buy Director bought 400 shares at $1.81 ($724)
- 4 Open-market buy Director bought 700 shares at an average $1.85 ($1,297)
- 4 Open-market buy Director bought 2,175 shares at an average $1.89 ($4,105)
- 4 Open-market buy Vice President & CSO bought 23,000 shares at $1.31 ($30,188)
- 4 Open-market buy President & CEO bought 51,000 shares at $1.31 ($66,938)
- 4 Open-market buy Director bought 400 shares at $2.00 ($800)
- 4/A Open-market buy Director bought 300 shares at $2.00 ($600)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 6,000 shares at $1.81 ($10,860)
- 4 Open-market buy Director bought 5,070 shares at an average $1.80 ($9,133)
- 4 Open-market buy Director bought 500 shares at $2.50 ($1,250)
- 4 Open-market buy Director bought 100 shares at $3.35 ($335)
- 4 Open-market buy Director bought 1,200 shares at $3.45 ($4,140)
Page 9 of 13 · 256 filings